...
机译:A Five-in-One First-in-Human Study To Assess Safety, Tolerability, and Pharmacokinetics of RO7049389, an Inhibitor of Hepatitis B Virus Capsid Assembly, after Single and Multiple Ascending Doses in Healthy Participants
Auckland Clin Studies, Auckland, New Zealand;
Roche Innovat Ctr Shanghai, I2O DIA, Shanghai, Peoples R China;
Roche Innovat Ctr Basel, Early Dev Safety, Basel, SwitzerlandRoche Pharma Prod Dev Shanghai, Biostat, Shanghai, Peoples R ChinaRoche Innovat Ctr Shanghai, Pharmaceut Sci, Shanghai, Peoples R China;
RO7049389; first-in-human study; safety; pharmacokinetics; drug-drug interaction; first in human; hepatitis B virus;